Avantor [AVTR] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
Avantor
NYSE
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Avantor wins in 7 metrics, Intuitive Surgical wins in 12 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Avantor | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.27 | 67.60 | Avantor |
| Price-to-Book Ratio | 1.23 | 9.71 | Avantor |
| Debt-to-Equity Ratio | 67.49 | 0.00 | Intuitive Surgical |
| PEG Ratio | 10.07 | 61.50 | Avantor |
| EV/EBITDA | 10.84 | 52.75 | Avantor |
| Profit Margin (TTM) | 10.31% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 7.63% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | 7.63% | 30.47% | Intuitive Surgical |
| Return on Equity | 11.73% | 16.04% | Intuitive Surgical |
| Return on Assets (TTM) | 3.24% | 9.02% | Intuitive Surgical |
| Free Cash Flow (TTM) | $692.00M | $1.30B | Intuitive Surgical |
| 1-Year Return | -54.44% | 2.29% | Intuitive Surgical |
| Price-to-Sales Ratio (TTM) | 1.16 | 18.95 | Avantor |
| Enterprise Value | $11.55B | $168.05B | Intuitive Surgical |
| EV/Revenue Ratio | 1.73 | 18.38 | Avantor |
| Gross Profit Margin (TTM) | 32.92% | 66.31% | Intuitive Surgical |
| Revenue per Share (TTM) | $10 | $26 | Intuitive Surgical |
| Earnings per Share (Diluted) | $1.01 | $7.15 | Intuitive Surgical |
| Beta (Stock Volatility) | 0.96 | 1.60 | Avantor |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Avantor vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Avantor | 1.01% | -15.33% | -15.77% | -4.69% | -40.61% | -46.32% |
| Intuitive Surgical | 0.09% | -2.34% | -12.14% | -12.37% | -19.41% | -10.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Avantor | -54.44% | -60.15% | -44.97% | -21.52% | -21.52% | -21.52% |
| Intuitive Surgical | 2.29% | 98.88% | 107.77% | 705.27% | 1,251.37% | 5,591.00% |
Performance & Financial Health Analysis: Avantor vs Intuitive Surgical
| Metric | AVTR | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $7.76B | $173.27B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 19,256,440 | 2,569,790 |
| 90 Day Avg. Volume | 13,953,210 | 1,960,720 |
| Last Close | $11.49 | $470.23 |
| 52 Week Range | $10.82 - $27.83 | $425.00 - $616.00 |
| % from 52W High | -58.70% | -23.66% |
| All-Time High | $44.37 (Sep 20, 2021) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -74.10% | -23.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.21% |
| Quarterly Earnings Growth | -0.30% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.29% |
| Operating Margin (TTM) | 0.08% | 0.30% |
| Return on Equity (TTM) | 0.12% | 0.16% |
| Debt to Equity (MRQ) | 67.49 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.22 | $49.79 |
| Cash per Share (MRQ) | $0.66 | $14.86 |
| Operating Cash Flow (TTM) | $681.80M | $2.83B |
| Levered Free Cash Flow (TTM) | $688.84M | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Avantor vs Intuitive Surgical
| Metric | AVTR | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.27 | 67.60 |
| Forward P/E | 10.07 | 61.50 |
| PEG Ratio | 10.07 | 61.50 |
| Price to Sales (TTM) | 1.16 | 18.95 |
| Price to Book (MRQ) | 1.23 | 9.71 |
| Market Capitalization | ||
| Market Capitalization | $7.76B | $173.27B |
| Enterprise Value | $11.55B | $168.05B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.73 | 18.38 |
| Enterprise to EBITDA | 10.84 | 52.75 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.60 |
| Book Value per Share (MRQ) | $9.22 | $49.79 |
Financial Statements Comparison: Avantor vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AVTR | ISRG |
|---|---|---|
| Revenue/Sales | $1.58B | $2.44B |
| Cost of Goods Sold | $1.05B | $822.10M |
| Gross Profit | $534.90M | $1.62B |
| Research & Development | N/A | $313.30M |
| Operating Income (EBIT) | $147.40M | $743.40M |
| EBITDA | $230.80M | $898.70M |
| Pre-Tax Income | $85.70M | $832.10M |
| Income Tax | $21.20M | $167.90M |
| Net Income (Profit) | $64.50M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AVTR | ISRG |
|---|---|---|
| Cash & Equivalents | $315.70M | $2.57B |
| Total Current Assets | $2.28B | $7.66B |
| Total Current Liabilities | $2.03B | $1.54B |
| Long-Term Debt | $3.28B | N/A |
| Total Shareholders Equity | $6.10B | $17.21B |
| Retained Earnings | $2.27B | $7.14B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AVTR | ISRG |
|---|---|---|
| Operating Cash Flow | $86.60M | $833.10M |
| Capital Expenditures | N/A | $-116.60M |
| Free Cash Flow | $81.30M | $465.00M |
| Debt Repayment | $-31.30M | N/A |
| Common Stock Repurchase | $-4.90M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AVTR | ISRG |
|---|---|---|
| Shares Short | 40.07M | 3.87M |
| Short Ratio | 3.41 | 2.37 |
| Short % of Float | 0.08% | 0.01% |
| Average Daily Volume (10 Day) | 19,256,440 | 2,569,790 |
| Average Daily Volume (90 Day) | 13,953,210 | 1,960,720 |
| Shares Outstanding | 680.80M | 356.60M |
| Float Shares | 664.21M | 356.33M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.00% | 0.89% |
Dividend Analysis & Yield Comparison: Avantor vs Intuitive Surgical
| Metric | AVTR | ISRG |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |